Terms: = Germ cell tumor AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
100 results:
1. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
[TBL] [Abstract] [Full Text] [Related]
2. 5-Hydroxymethylcytosine Profiling of cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma.
Chennakesavalu M; Moore K; Chaves G; Veeravalli S; TerHaar R; Wu T; Lyu R; Chlenski A; He C; Piunti A; Applebaum MA
JCO Precis Oncol; 2024 Jan; 8():e2300297. PubMed ID: 38295320
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. IFN-γ Triggered IFITM2 Expression to Induce Malignant Phenotype in Elderly GBM.
Liang T; Wang X; Wang Y; Ma W
J Mol Neurosci; 2023 Dec; 73(11-12):946-955. PubMed ID: 37889394
[TBL] [Abstract] [Full Text] [Related]
5. tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.
Ugolini F; De Logu F; Iannone LF; Brutti F; Simi S; Maio V; de Giorgi V; Maria di Giacomo A; Miracco C; Federico F; Peris K; Palmieri G; Cossu A; Mandalà M; Massi D; Laurino M
Am J Pathol; 2023 Dec; 193(12):2099-2110. PubMed ID: 37734590
[TBL] [Abstract] [Full Text] [Related]
6. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed cell Death in Lower Grade Glioma.
Ma W; Mei P
World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
[TBL] [Abstract] [Full Text] [Related]
7. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract] [Full Text] [Related]
8. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
9. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract] [Full Text] [Related]
11. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract] [Full Text] [Related]
12. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
Harrabi SB; von Nettelbladt B; Gudden C; Adeberg S; Seidensaal K; Bauer J; Bahn E; Mairani A; Alber M; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Feb; 167():211-218. PubMed ID: 34973277
[TBL] [Abstract] [Full Text] [Related]
13. Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Huber V; Di Guardo L; Lalli L; Giardiello D; Cova A; Squarcina P; Frati P; Di Giacomo AM; Pilla L; Tazzari M; Camisaschi C; Arienti F; Castelli C; Rodolfo M; Beretta V; Di Nicola M; Maio M; Del Vecchio M; de Braud F; Mariani L; Rivoltini L
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589521
[TBL] [Abstract] [Full Text] [Related]
14.
Li J; Zhang Q; Ge P; Zeng C; Lin F; Wang W; Zhao J
Dis Markers; 2020; 2020():8888085. PubMed ID: 33299501
[TBL] [Abstract] [Full Text] [Related]
15. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract] [Full Text] [Related]
16. Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine tumors.
Tabrizi S; Alshalalfa M; Mahal BA; Davicioni E; Liu Y; Mouw KW; Feng F; Nguyen PL; Muralidhar V
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):936-940. PubMed ID: 32585335
[TBL] [Abstract] [Full Text] [Related]
17. Coagulation factor 2 thrombin receptor promotes malignancy in glioma under SOX2 regulation.
Gao G; Yang M; Wang F; Dang G; Zhang X; Zhao J; Wang X; Jin B
Aging (Albany NY); 2020 Jun; 12(11):10594—10613. PubMed ID: 32507767
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic and predictive value of an immune infiltration signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Li CB; Huo XL; Li H; Hao SY; Wu Z; Wang L; Li D; Zhang JT
JCI Insight; 2020 Mar; 5(8):. PubMed ID: 32229719
[TBL] [Abstract] [Full Text] [Related]
19. Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
Fathi Kazerooni A; Akbari H; Shukla G; Badve C; Rudie JD; Sako C; Rathore S; Bakas S; Pati S; Singh A; Bergman M; Ha SM; Kontos D; Nasrallah M; Bagley SJ; Lustig RA; O'Rourke DM; Sloan AE; Barnholtz-Sloan JS; Mohan S; Bilello M; Davatzikos C
JCO Clin Cancer Inform; 2020 Mar; 4():234-244. PubMed ID: 32191542
[TBL] [Abstract] [Full Text] [Related]
20. The Role of mPRδ and mPRε in Human Glioblastoma cells: Expression, Hormonal Regulation, and Possible clinical outcome.
Del Moral-Morales A; González-Orozco JC; Capetillo-Velázquez JM; Piña-Medina AG; Camacho-Arroyo I
Horm Cancer; 2020 Apr; 11(2):117-127. PubMed ID: 32077034
[TBL] [Abstract] [Full Text] [Related]
[Next]